Cardiovascular diseases (CVDs) remain the foremost cause of morbidity and mortality worldwide, accounting for a substantial burden on healthcare systems, economies, and society. Traditional risk factors do not fully explain residual cardiovascular risk, highlighting the role of insulin resistance (IR) as a key pathophy...
M. Cherska, Khrystyna Kukharchuk, A. Ceasovschih et al.· Lipids in Health and Disease· 0 citations
Cardiovascular–kidney–metabolic (CKM) syndrome is driven by the interplay of visceral adiposity, insulin resistance, chronic inflammation, oxidative stress, and progressive kidney dysfunction. These mechanisms generate a distinct atherogenic dyslipidaemic phenotype characterised by elevated triglycerides (TG), reduced...
A. Ceasovschih, Y. Şener, M. Arıcı et al.· International Journal of Mol...· 0 citations
Patients presenting with decompensated heart failure had a more pronounced inflammatory profile than those with compensated heart failure, and higher CRP and SII levels were associated with in-hospital mortality in adjusted analyses.
Elena Cojocaru, V. Șorodoc, Cristian Cojocaru et al.· Metabolites· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.